Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

FULGENT THERAPEUTICS LLC

Subsidiary ofFULGENT GENETICS, INC.UEI: JVZDRESJLD82CAGE: 7BRL2

FULGENT THERAPEUTICS LLC is a federal contractor, registered under UEI JVZDRESJLD82 and CAGE code 7BRL2. It has been awarded $58,229,840 in federal contracts. Primary work spans Medical Laboratories, Pharmaceutical Preparation Manufacturing, and Other NAICS codes (2 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services, Department Of Veterans Affairs, and Department Of Homeland Security.

Contact Information

Registration and classification details

Registration

UEI Code

JVZDRESJLD82

CAGE Code

7BRL2

Entity Structure

Partnership or Limited Liability Partnership

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability CompanyMinority-Owned BusinessAsian-Pacific American Owned

NAICS Codes

541714Research and Development in Biotechnology (except Nanobiotechnology)
621511Medical Laboratories(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Fulgent Therapeutics LLC specializes in advanced molecular diagnostics and genomic sequencing services for federal health programs, with deep expertise in germline genetic testing, pharmacogenomics, and SARS-CoV-2 genomic analysis. The company delivers high-complexity clinical laboratory services us...

Fulgent Therapeutics LLC specializes in advanced molecular diagnostics and genomic sequencing services for federal health programs, with deep expertise in germline genetic testing, pharmacogenomics, and SARS-CoV-2 genomic analysis. The company delivers high-complexity clinical laboratory services using next-generation sequencing platforms such as Illumina HiSeq, enabling precision medicine applications through variant detection, haplotype analysis, and molecular biomarker identification. Their technical capabilities span molecular assay development, bioinformatics pipeline validation, and regulatory-compliant reporting for clinical decision support, with a demonstrated focus on hereditary disease risk assessment and drug response profiling. Differentiators include rapid turnaround for high-volume genomic testing and adherence to CLIA and CAP standards in a clinical laboratory setting. The contractor maintains a consistent relationship with the Department of Veterans Affairs, providing targeted genetic testing services to support veteran healthcare personalization, including pharmacogenomic guidance for chronic pain and psychiatric medication management. They also deliver genomic sequencing support to the Department of Health and Human Services, particularly for public health surveillance and infectious disease monitoring, indicating a strong alignment with federal biomedical research and population health initiatives. Fulgent Therapeutics operates primarily under NAICS 621511 (Medical Laboratories), focusing on clinical-grade genetic and molecular diagnostics, with supplementary experience in pharmaceutical preparation manufacturing for genetic testing reagents and testing laboratory services for genomic data generation. Their market positioning is centered on precision diagnostics for federal healthcare systems, bridging clinical genomics with operational scalability in government settings. As a small business structured as a 2K entity based in El Monte, California, Fulgent Therapeutics lacks federal certifications but maintains a focused presence in the federal life sciences market through specialized, high-compliance laboratory operations. Their geographic footprint supports direct service delivery to VA medical centers and HHS research partners across the western United States.

Key Performance Metrics

Awards Count

24

All time

Active

2

Currently performing

Completed

22

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
Awards by Agency Over Time
Awards by Place of Performance

Compete with FULGENT THERAPEUTICS LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for FULGENT THERAPEUTICS LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in FULGENT THERAPEUTICS LLC's top NAICS codes and agencies

NAICS: 621511
New
Federal
Q301-- New Lab Staffing Contract Fiscal Year 2027-Path & Lab
Solicitation # 36C24926Q0334_1
The Department of Veterans Affairs, Network Contracting Office 9, is soliciting quotes for a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide laboratory staffing services at the Lt. Col Luke Weathers Jr. VAMC in Memphis, Tennessee. The performance period runs from April 1, 2027, to March 31, 2032, with a total estimated value of 41.5 million dollars. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The contractor is required to provide up to 16 full-time equivalent key personnel to support three daily shifts, with a guaranteed minimum of 3,402 hours and a maximum not to exceed 340,240 hours. Award will be based on a best-value determination using comparative analysis of administrative compliance, past performance, technical capability, and price. Technical evaluation specifically emphasizes the quality of certifications and the effectiveness of the contractor's contingency plan for ensuring uninterrupted services. Contractors must adhere to strict clinical standards, including JCAHO, CAP, FDA, and CLIA regulations, and comply with all VA security, confidentiality, and HIPAA requirements. Proposals must be submitted electronically by October 14, 2026, and must include specific certifications regarding the Immigration and Nationality Act, organizational conflicts of interest, and OIG exclusion lists.
249-NETWORK Contract Office 9 (36C249)

POSTED

3 days ago

DEADLINE

in 2 days
View Details
NAICS: 621511
New
Federal
Q522--Heart Transplant Biopsies Consultation Services (Examination and Interpretation)-Light Microscopy, Immunofluorescence, and Electron Microscopy-Salt Lake City VA Health Care System
Solicitation # 36C25926Q0622
The Department of Veterans Affairs, Network Contracting Office 19, is conducting market research through a Sources Sought Notice for heart transplant biopsy consultation services at the George E. Wahlen VA Medical Center in Salt Lake City, Utah. The requirement is structured as a base year with four option years and involves the professional examination and interpretation of biopsy slides using light microscopy, immunofluorescence, and electron microscopy. The contractor is responsible for retrieving slides via local courier within two hours during business hours and providing both verbal and final electronic reports within 24 hours of specimen receipt. Additionally, the contractor must attend weekly transplant tumor board meetings at 07:00 MST and perform retrospective case reviews as needed. Qualified providers must hold unrestricted medical licenses in the United States, maintain current malpractice insurance, and demonstrate proficiency in English. The government is seeking information from interested sources, including business size, GSA contract status, and capabilities regarding the specific microscopy requirements. Responses must be submitted by October 16, 2026, and must include a completed market research questionnaire and a capabilities statement not exceeding eight pages. This notice is for planning purposes only and does not constitute a formal solicitation or a commitment to award a contract.
Network Contract Office 19 (36C259)

POSTED

4 days ago

DEADLINE

in 4 days
View Details
NAICS: 325412
New
Federal
6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center
Solicitation # 36C24427Q0018
The Department of Veterans Affairs, Network Contracting Office 4, is soliciting quotations for an indefinite-quantity contract to provide essential radiopharmaceuticals and calibration sources for the Corporal Michael J. Crescenz VA Medical Center Nuclear Medicine Department. The contract covers a five-year period of performance from November 1, 2026, to October 31, 2031, consisting of a base year and four option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, NHPP, FDA, and OSHA. Deliveries are to be made to a secure location at the medical center, with routine orders due by 8:00 AM the following workday and same-day deliveries required within two hours of order placement during normal business hours. The scope of work includes the supply of various radiopharmaceutical kits and calibration sources, such as Co57 and Tc99m variants. Contractors must ensure all radioactive materials are clearly labeled with proper class and exposure levels, and unit doses must include preparation and expiration details. Additionally, the vendor must provide bar-labeled inserts compatible with the PineStar Nuclear Medicine Information Management System or provide a compatible system, including data migration and training, at no additional cost. Award will be based on a comparative evaluation of price and past performance, with a preference for HUBZone Small Business Concerns. Quotations must be submitted electronically to the Contracting Officer in two parts: a price quotation and past performance information from the last three years. Invoicing is to be handled monthly and submitted electronically via the Austin Payment Center.
244-NETWORK Contract Office 4 (36C244)

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 561990
New
Federal
Intent to Sole Source Fire Suppression and Emergency Response Service
Solicitation # 36C26326Q0635_1
The Department of Veterans Affairs, Network Contracting Office 23, intends to award a sole source contract to the City of Minneapolis for fire suppression and emergency response services at the Veterans Affairs Medical Center in Minneapolis, Minnesota, including buildings at Fort Snelling. This action is being taken under the authority of FAR 6.103-1 and FAR 12.102(a), as the government has determined that only one responsible source can satisfy the agency requirements. Interested parties wishing to challenge this intent must submit a capabilities statement and answer specific organizational questions by October 18, 2026, to demonstrate their ability to provide the required services. The scope of work requires the contractor to provide 24/7 contractor-owned and operated fire suppression and emergency medical services, including responses to fire alarms, hazardous material spills, confined space rescues, and elevator entrapments. Key technical requirements include a maximum response time of eight minutes, a minimum of four certified professional firefighters, and at least two fire pumper apparatus with a minimum capacity of 1200 gpm. The contractor must maintain a minimum ISO rating of 3, adhere to NFPA, OSHA, and State of Minnesota standards, and participate in mutual aid agreements with at least two other municipal fire departments. Additional deliverables include the submission of a pre-fire plan within seven days of inspection and a phase-in plan within ten days of contract award.
Department Of Veterans Affairs

POSTED

4 days ago

DEADLINE

in 7 days
View Details